Evaluation of HCD- and CID-type fragmentation within their respective detection platforms for murine phosphoproteomics.
about
Recent findings and technological advances in phosphoproteomics for cells and tissuesMass spectrometry-based detection and assignment of protein posttranslational modificationsComputational phosphoproteomics: from identification to localizationAnalyzing the modification of the Shewanella oneidensis MR-1 flagellar filamentPerformance Investigation of Proteomic Identification by HCD/CID Fragmentations in Combination with High/Low-Resolution Detectors on a Tribrid, High-Field Orbitrap InstrumentProtein Structural Analysis via Mass Spectrometry-Based ProteomicsComplementary IMAC enrichment methods for HLA-associated phosphopeptide identification by mass spectrometry.Quantitative proteomic analysis of histone modificationsPlatform dependencies in bottom-up hydrogen/deuterium exchange mass spectrometry.Factorial experimental designs elucidate significant variables affecting data acquisition on a quadrupole Orbitrap mass spectrometer.The coming of age of phosphoproteomics--from large data sets to inference of protein functionsLarge-scale label-free phosphoproteomics: from technology to data interpretation.Optimization of the β-elimination/michael addition chemistry on reversed-phase supports for mass spectrometry analysis of O-linked protein modificationsPhosphopeptide enrichment by covalent chromatography after derivatization of protein digests immobilized on reversed-phase supportsLaser ablation electrospray ionization high-resolution mass spectrometry for regulatory screening of domoic acid in shellfish.Comparison of data analysis parameters and MS/MS fragmentation techniques for quantitative proteome analysis using isobaric peptide termini labeling (IPTL).Quantitative maps of protein phosphorylation sites across 14 different rat organs and tissues.Discovery of O-GlcNAc-6-phosphate modified proteins in large-scale phosphoproteomics data.Robust phosphoproteome enrichment using monodisperse microsphere-based immobilized titanium (IV) ion affinity chromatography.Protein analysis by shotgun/bottom-up proteomicsA large synthetic peptide and phosphopeptide reference library for mass spectrometry-based proteomics.LuciPHOr: algorithm for phosphorylation site localization with false localization rate estimation using modified target-decoy approach.Urinary proteomic and non-prefractionation quantitative phosphoproteomic analysis during pregnancy and non-pregnancy.PhosSA: Fast and accurate phosphorylation site assignment algorithm for mass spectrometry data.Proteomic challenges: sample preparation techniques for microgram-quantity protein analysis from biological samples.Optimization of titanium dioxide and immunoaffinity-based enrichment procedures for tyrosine phosphopeptide using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.A comparative study of phosphopeptide-selective techniques for a sub-proteome of a complex biological sample.Reduced-representation Phosphosignatures Measured by Quantitative Targeted MS Capture Cellular States and Enable Large-scale Comparison of Drug-induced PhenotypesRefined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome.Peptide identification by tandem mass spectrometry with alternate fragmentation modes.Improving data quality and preserving HCD-generated reporter ions with EThcD for isobaric tag-based quantitative proteomics and proteome-wide PTM studies.Chemoenzymatic method for glycomics: Isolation, identification, and quantitation.Comparison of the LTQ-Orbitrap Velos and the Q-Exactive for proteomic analysis of 1-1000 ng RAW 264.7 cell lysate digests.The current state of the art of quantitative phosphoproteomics and its applications to diabetes researchEnergy dependence of HCD on peptide fragmentation: stepped collisional energy finds the sweet spotEnhanced detection of multiply phosphorylated peptides and identification of their sites of modification.Alpha-synuclein post-translational modifications as potential biomarkers for Parkinson disease and other synucleinopathies.Mass Spectrometry-based Proteomics and Peptidomics for Systems Biology and Biomarker Discovery.Reliable determination of site-specific in vivo protein N-glycosylation based on collision-induced MS/MS and chromatographic retention time.Technologies and challenges in large-scale phosphoproteomics.
P2860
Q26781752-39FC7A04-70E2-4004-8D4B-4E7A232C7C40Q27001576-3D0BCB4E-7586-4701-874D-7E2FD0D028C7Q27005933-1A867423-6414-40EE-B0A5-36AAC3D4D831Q28536913-5B89D8C9-F08C-44B4-86EE-F35B9EB4B134Q28553325-D61BA789-8E11-49EA-BDFD-9EEE0EB3ECB6Q28818005-7E9753A4-5BD2-4ED3-88D0-0AD4125D684DQ30278896-0B384D3F-982C-43A9-9AB3-9A9F1BD6CD01Q30375585-B97F215D-DF5D-4727-BDAB-F0E3549A904FQ30424252-606036CF-4193-4E01-A0BC-6EB2FF709C3EQ30659144-9CE06685-F92A-4CC5-BD85-FC67DF60A7ADQ30666963-02969D5A-07CC-473E-80B3-087C57E72FEAQ30868595-9E3913E6-24E9-4AB1-B57E-ADF7DE06A22FQ31136381-7D7380FA-4648-4310-9DC7-9B004DB1EAA9Q31136391-1FED7B26-A897-41C4-BCDF-4D44FAA2191FQ33698238-7819C915-7E59-45E5-B02C-01897CA6B7A1Q34213175-C70BA6B0-BCC4-42A9-B246-81E6CC13799BQ34279410-68AB49C4-8291-4C44-AF25-9FEDC3F708FEQ34349212-174A6029-3555-48BF-B268-DCABBB6FEE01Q34580603-679215EC-7858-4DD0-92FE-27C4690D6C16Q34600986-59F09C38-0C33-4E12-A2B2-B893BC4F1400Q34728031-92A1ADFA-3228-486C-A7FF-76A0392296C5Q34897925-93BE8294-387A-47D6-9B2A-53E0918A3BDCQ35038507-C5337729-1C66-4304-809F-A65F40F6745DQ35102004-23DFECF0-9D7B-43D7-822A-39ACB5B6AE04Q35139099-142C6085-ACE1-49DA-B6A4-807BA29D0D67Q35500628-BE04CA88-2A9C-4805-ADC5-6CD9DD4F7376Q35926273-0C3AEB69-D4B2-4053-894B-1526C0F97530Q35935148-DDFD0109-2344-47DA-8EC8-F17DD2983D8CQ36136732-AD3D185D-CF19-4CBA-A423-C09F7E0B079BQ36211835-E24A4280-AAEB-4348-ADF9-6DFE870F8A0EQ36342472-ABD36E3A-B12E-469E-AF27-B2C989DD6C3EQ36471241-C23A3A5A-803C-4703-8EF0-B1E68C513F43Q36903986-46A5F4AA-5E2D-4F4E-AEAC-369EB999541FQ37080936-F6A9BEE5-791D-41AB-849D-E121381D71FBQ37274183-2713EF6B-A7A4-4EE6-AC08-FB2828F17E28Q37344321-70ECC8B1-142F-4453-B2C6-DDE4DB914789Q37388974-ABAA006B-83C8-453F-92DB-334DD5433296Q37552845-9B4113B5-405F-44DF-8E0C-A6CA76CA75BAQ37705225-248DF999-5C97-4319-9304-38B5BC6CA214Q38081123-36A28A8D-9939-491A-B345-C88FA98E7990
P2860
Evaluation of HCD- and CID-type fragmentation within their respective detection platforms for murine phosphoproteomics.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Evaluation of HCD- and CID-typ ...... for murine phosphoproteomics.
@ast
Evaluation of HCD- and CID-typ ...... for murine phosphoproteomics.
@en
type
label
Evaluation of HCD- and CID-typ ...... for murine phosphoproteomics.
@ast
Evaluation of HCD- and CID-typ ...... for murine phosphoproteomics.
@en
prefLabel
Evaluation of HCD- and CID-typ ...... for murine phosphoproteomics.
@ast
Evaluation of HCD- and CID-typ ...... for murine phosphoproteomics.
@en
P2093
P2860
P50
P356
P1476
Evaluation of HCD- and CID-typ ...... s for murine phosphoproteomics
@en
P2093
Mathew E Sowa
Wilhelm Haas
P2860
P304
M111.009910
P356
10.1074/MCP.M111.009910
P577
2011-09-13T00:00:00Z